Effect of metformin on proliferative markers in women with endometrial carcinoma: Systematic review and meta-analysis.

MLA

Shareef, Mohammad Abrar, et al. “Effect of Metformin on Proliferative Markers in Women with Endometrial Carcinoma: Systematic Review and Meta-Analysis.” Turkish Journal of Obstetrics and Gynecology, vol. 19, no. 1, Mar. 2022, pp. 35–44. EBSCOhost, https://doi.org/10.4274/tjod.galenos.2022.26257.

APA

Shareef, M. A., Sofy, A. A., Abdelsattar, A. T., Masoud, A. T., Farhat, A. M., & Maarouf, H. (2022). Effect of metformin on proliferative markers in women with endometrial carcinoma: Systematic review and meta-analysis. Turkish Journal of Obstetrics and Gynecology, 19(1), 35–44. https://doi.org/10.4274/tjod.galenos.2022.26257

Chicago

Shareef, Mohammad Abrar, Ahmed Adel Sofy, Ahmed Taha Abdelsattar, Ahmed Taher Masoud, Abdullah Mohamed Farhat, and Hiba Maarouf. 2022. “Effect of Metformin on Proliferative Markers in Women with Endometrial Carcinoma: Systematic Review and Meta-Analysis.” Turkish Journal of Obstetrics and Gynecology 19 (1): 35–44. doi:10.4274/tjod.galenos.2022.26257.